Development of Gene Therapy Using Prostate‐specific Membrane Antigen Promoter/Enhancer with Cre Recombinase/LoxP System for Prostate Cancer Cells under Androgen Ablation Condition

To enhance the efficacy of suicide gene therapy for prostate cancer under androgen deprivation, we designed a promoter system that consists of the prostate‐specific membrane antigen (PSMA) promoter/enhancer (PEPM) and Cre‐loxP DNA recombination system. We constructed two kinds of plasmids. One plasm...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Jpn J Cancer Res
Egile Nagusiak: Ikegami, Shusei, Tadakuma, Takushi, Suzuki, Satoshi, Yoshimura, Ichiro, Asano, Tomohiko, Hayakawa, Masamichi
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Blackwell Publishing Ltd 2002
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5926883/
https://ncbi.nlm.nih.gov/pubmed/12417046
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1349-7006.2002.tb01218.x
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak